Catalytic Wealth Ria, LLC Vera Therapeutics, Inc. Transaction History
Catalytic Wealth Ria, LLC
- $1.22 Trillion
- Q2 2025
A detailed history of Catalytic Wealth Ria, LLC transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Catalytic Wealth Ria, LLC holds 13,567 shares of VERA stock, worth $309,191. This represents 0.03% of its overall portfolio holdings.
Number of Shares
13,567Holding current value
$309,191% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding VERA
# of Institutions
196Shares Held
64MCall Options Held
723KPut Options Held
186K-
Avoro Capital Advisors LLC New York, NY5.7MShares$130 Million2.22% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.75MShares$108 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$76.1 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$67.5 Million19.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.92MShares$66.5 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $616M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...